GlassScriptPhysician profile
Ahmad Said
NPI 1588013932
$3,171.41
in general payments reported to CMS, 2019-2025
16 companies · $243 in 2025
The $243 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.49 · 2022: $915 · 2023: $507 · 2024: $1,481 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,511 · Travel and Lodging: $276 · Education: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,511.46 |
| Travel and Lodging | $276.07 |
| Education | $265.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,125.23 | 2022-2024 | Cardiomems, Xience Skypoint, Perclose Prostyle |
| Intuitive Surgical, INC. | $276.07 | 2024 | |
| Penumbra, INC. | $264.77 | 2024 | Indigo System |
| Boston Scientific Corporation | $231.69 | 2024 | Eluvia |
| Shockwave Medical, INC | $209.25 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $164.28 | 2023 | Onyx Frontier |
| Livanova USA, INC. | $149.20 | 2022 | |
| Abiomed | $145.71 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $143.89 | 2021-2023 | Lifevest |
| Chiesi USA, INC. | $70.29 | 2024 | Kengreal |
| United Therapeutics Corporation | $61.13 | 2024-2025 | Tyvaso, Tyvaso |
| Stryker Corporation | $58.83 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Actelion Pharmaceuticals US, INC. | $30.13 | 2025 | Opsumit, Uptravi |
| W. L. Gore & Associates, INC. | $23.36 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Amgen INC. | $14.06 | 2025 | Repatha |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $13.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmad Said listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.